Cargando…
Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and In Vivo Studies
[Image: see text] Chagas disease is a tropical infection caused by the protozoan parasite Trypanosoma cruzi and a global public health concern. It is a paradigmatic example of a chronic disease without an effective treatment. Current treatments targeting T. cruzi are limited to two obsolete nitrohet...
Autores principales: | Martín-Escolano, Rubén, Etxebeste-Mitxeltorena, Mikel, Martín-Escolano, Javier, Plano, Daniel, Rosales, María J., Espuelas, Socorro, Moreno, Esther, Sánchez-Moreno, Manuel, Sanmartín, Carmen, Marín, Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480776/ https://www.ncbi.nlm.nih.gov/pubmed/33871252 http://dx.doi.org/10.1021/acsinfecdis.1c00048 |
Ejemplares similares
-
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
por: Etxebeste-Mitxeltorena, Mikel, et al.
Publicado: (2021) -
Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion
por: Martín-Escolano, Rubén, et al.
Publicado: (2021) -
Insights into Chagas treatment based on the potential of bacteriocin AS-48
por: Martín-Escolano, Rubén, et al.
Publicado: (2019) -
Oral Efficacy of a Diselenide Compound Loaded in Nanostructured
Lipid Carriers in a Murine Model of Visceral Leishmaniasis
por: Etxebeste-Mitxeltorena, Mikel, et al.
Publicado: (2021) -
Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe(3)O(4) Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor
por: Galarreta-Rodriguez, Itziar, et al.
Publicado: (2023)